SARS CoV-2 (COVID-19) Testing
Who We Are
What We Do
Markets We Serve
New Coronavirus Nucleic Acid Detection Kit
Probe-based PCR assay using fluorescent-labeled probes specific to the 2019 coronavirus (SARS-CoV-2). For emergency use authorization only.
SARS-CoV-2 Real-time RT-PCR Assay
CE-IVD marked and intended for in vitro diagnostic use in Europe.

Our mission of innovating for a healthier world is at the heart of everything we do. We help customers make smarter decisions, earlier diagnoses, more effective treatments and scientific breakthroughs.

Detect and identify disease, contaminants and biological pathways
Visualize biological, cellular and clinical insights
Unify, visualize and analyze your data
Customized laboratory management, research and clinical solutions
Screening and diagnostic solutions for earlier clinical insights
Life Sciences
Disease research, drug discovery and QA/QC for faster drugs to market
Food safety and quality testing for feeding a growing population
Air, water and soil testing for a safer planet
Chemical and material testing for better products

Key Trends and Insights

SARS-CoV-2 PCR Detection Workflow

High quality RNA extraction and automation with flexible throughput and full traceability.

SARS-CoV-2 PCR Detection Workflow
FDA Provides Emergency Use Authorization to PerkinElmer for COVID-19 Testing
PerkinElmer Technologies Being Used to Study Ocean Pollution on 2-Year Voyage Around the World
Webcast: Smart Solutions for Future Odor and Emission Requirements
The Role Of In Vivo Imaging In Drug Discovery & Development

Product Catalog

Browse Products

See all products available for online ordering, view your pricing, check availability, place online orders and check order status.

Quick Order

Enter product part numbers and quantities to quickly add products to your cart

Upcoming Events

ISBER 2020 Annual Meeting

April 15 - April 17, 2020 |
Anaheim, USA

Cancelled due to Coronavirus. International Society for Biological and Environmental Repositories: ISBER is a global biobanking organization which creates opportunities for networking, education, and innovations and harmonizes approaches to evolving challenges in biological and environmental repositories..

Leads Discovered: Accelerating Drug Discovery with Novel Tools for Structure & Sequence Activity Relationship Analysis New Component

April 22 - April 22, 2020 |
Boston, USA

SAR tools have long been the purview of small molecule medicinal chemists. As Biologics and sequence-based therapeutics become more pervasive, a new set of Sequence-Activity-Relationship tools are gaining importance in drug discovery. This webcast will showcase how AbbVie has been working with PerkinElmer solutions that extend their SAR analysis capabilities to include both small molecules and biologics in a single extensible platform that promises to expedite the lead discovery process..